Loading company…
Cambridge-based biopharmaceutical company founded in 1998, developing therapeutics for unmet healthcare needs.
Founded in 1998 and headquartered in Cambridge, UK, Paradigm Therapeutics Ltd researches and develops therapeutics for unmet medical needs, including drug candidates for a range of diseases. Robert Ryan is the CEO. In March 2007, Takeda Pharmaceutical Company Limited acquired the company after an investment round that raised GBP 7.000 mn, with participation from Avlar BioVentures and LDC.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in